Insiders · Profile

Bispham Barbara Harlin

See Remarks at CRESCENT BIOPHARMA. Filing since 22 Jun 2026. CIK 0002075230

Company
Date
Role
Action
Shares
Amount
Of holding
16 Sep 2026
See Remarks
Sold on a plan
620
$11.10K
3.2%
22 Jun 2026
See Remarks
Sold on a plan
1,218
$21.91K
5.9%
2 decisions on file.